blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3361253

EP3361253 - DEVICE FOR THE TARGETED TESTING AND INDICATION OF THE ABSENCE OR PRESENCE OF ANALYTES IN A LIQUID SAMPLE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  09.10.2020
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  01.11.2019
FormerGrant of patent is intended
Status updated on  14.07.2019
FormerExamination is in progress
Status updated on  07.02.2019
FormerRequest for examination was made
Status updated on  13.07.2018
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Protzek Gesellschaft für Biomedizinische Technik GmbH
Industriestrasse 38
4415 Lausen / CH
[2020/08]
Former [2018/33]For all designated states
Protzek Gesellschaft für Biomedizinische Technik GmbH
Heulenlochweg 6
4133 Prattein / CH
Inventor(s)01 / PROTZEK, Christoph
Tüllinger Straße 36
79539 Lörrach / DE
 [2018/33]
Representative(s)Patentanwälte Dörner & Kötter PartG mbB
Körnerstrasse 27
58095 Hagen / DE
[2018/33]
Application number, filing date17155143.508.02.2017
[2018/33]
Filing languageDE
Procedural languageDE
PublicationType: A1 Application with search report 
No.:EP3361253
Date:15.08.2018
Language:DE
[2018/33]
Type: B1 Patent specification 
No.:EP3361253
Date:04.12.2019
Language:DE
[2019/49]
Search report(s)(Supplementary) European search report - dispatched on:EP06.07.2017
ClassificationIPC:G01N33/53, G01N21/84
[2018/33]
CPC:
G01N33/54386 (EP); G01N33/54388 (US); B01L3/5055 (EP);
B01L2300/0825 (EP); B01L2300/126 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/33]
TitleGerman:VORRICHTUNG ZUR GEZIELTEN PRÜFUNG UND ANZEIGE DER AB- BZW. ANWESENHEIT VON ANALYTEN IN EINER FLÜSSIGEN PROBE[2018/33]
English:DEVICE FOR THE TARGETED TESTING AND INDICATION OF THE ABSENCE OR PRESENCE OF ANALYTES IN A LIQUID SAMPLE[2018/33]
French:DISPOSITIF DE CONTRÔLE CIBLÉ ET D'AFFICHAGE DE LA PRÉSENCE OU DE L'ABSENCE D'ANALYTES DANS UN ÉCHANTILLON LIQUIDE[2018/33]
Examination procedure08.02.2017Date on which the examining division has become responsible
01.03.2018Amendment by applicant (claims and/or description)
01.03.2018Examination requested  [2018/33]
11.02.2019Despatch of a communication from the examining division (Time limit: M04)
17.04.2019Reply to a communication from the examining division
15.07.2019Communication of intention to grant the patent
28.10.2019Fee for grant paid
28.10.2019Fee for publishing/printing paid
28.10.2019Receipt of the translation of the claim(s)
Opposition(s)07.09.2020No opposition filed within time limit [2020/46]
Fees paidRenewal fee
25.01.2019Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.02.2017
AL04.12.2019
CY04.12.2019
CZ04.12.2019
DK04.12.2019
EE04.12.2019
ES04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
MC04.12.2019
MK04.12.2019
MT04.12.2019
PL04.12.2019
RO04.12.2019
RS04.12.2019
SI04.12.2019
SK04.12.2019
SM04.12.2019
TR04.12.2019
IE08.02.2020
BG04.03.2020
NO04.03.2020
GR05.03.2020
IS04.04.2020
PT29.04.2020
[2022/32]
Former [2022/27]HU08.02.2017
AL04.12.2019
CY04.12.2019
CZ04.12.2019
DK04.12.2019
EE04.12.2019
ES04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
MC04.12.2019
MT04.12.2019
PL04.12.2019
RO04.12.2019
RS04.12.2019
SI04.12.2019
SK04.12.2019
SM04.12.2019
TR04.12.2019
IE08.02.2020
BG04.03.2020
NO04.03.2020
GR05.03.2020
IS04.04.2020
PT29.04.2020
Former [2021/08]AL04.12.2019
CZ04.12.2019
DK04.12.2019
EE04.12.2019
ES04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
MC04.12.2019
PL04.12.2019
RO04.12.2019
RS04.12.2019
SI04.12.2019
SK04.12.2019
SM04.12.2019
IE08.02.2020
BG04.03.2020
NO04.03.2020
GR05.03.2020
IS04.04.2020
PT29.04.2020
Former [2020/51]AL04.12.2019
CZ04.12.2019
DK04.12.2019
EE04.12.2019
ES04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
MC04.12.2019
PL04.12.2019
RO04.12.2019
RS04.12.2019
SI04.12.2019
SK04.12.2019
SM04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
IS04.04.2020
PT29.04.2020
Former [2020/50]AL04.12.2019
CZ04.12.2019
DK04.12.2019
EE04.12.2019
ES04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
MC04.12.2019
RO04.12.2019
RS04.12.2019
SI04.12.2019
SK04.12.2019
SM04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
IS04.04.2020
PT29.04.2020
Former [2020/47]AL04.12.2019
CZ04.12.2019
DK04.12.2019
EE04.12.2019
ES04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
RO04.12.2019
RS04.12.2019
SK04.12.2019
SM04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
IS04.04.2020
PT29.04.2020
Former [2020/40]AL04.12.2019
CZ04.12.2019
EE04.12.2019
ES04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
RO04.12.2019
RS04.12.2019
SK04.12.2019
SM04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
IS04.04.2020
PT29.04.2020
Former [2020/37]AL04.12.2019
CZ04.12.2019
EE04.12.2019
ES04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
RO04.12.2019
RS04.12.2019
SK04.12.2019
SM04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
PT29.04.2020
Former [2020/36]AL04.12.2019
CZ04.12.2019
EE04.12.2019
ES04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
RO04.12.2019
RS04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
PT29.04.2020
Former [2020/35]AL04.12.2019
CZ04.12.2019
ES04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
RO04.12.2019
RS04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
Former [2020/34]AL04.12.2019
ES04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
RS04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
Former [2020/32]AL04.12.2019
FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
RS04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
Former [2020/26]FI04.12.2019
HR04.12.2019
LT04.12.2019
LV04.12.2019
RS04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
Former [2020/23]FI04.12.2019
LT04.12.2019
LV04.12.2019
BG04.03.2020
NO04.03.2020
GR05.03.2020
Former [2020/22]FI04.12.2019
LT04.12.2019
BG04.03.2020
NO04.03.2020
Former [2020/21]NO04.03.2020
Documents cited:Search[X]US2007092401  (LIAO FEIER [CN], et al) [X] 1-14 * paragraph [0023] - paragraph [0024] * * paragraph [0035] * * paragraph [0038] * * paragraph [0050] * * figures 2, 3A-3C,5 *;
 [A]WO2014043247  (FORCE DIAGNOSTICS INC [US]) [A] 1-14 * paragraph [0073] * * paragraph [0077] ** figure - *;
 [A]WO2016064545  (BIOMEDOMICS INC [US]) [A] 1-14 * page 7, line 10 - line 16 * * page 8, line 29 - line 32 * * page 17, line 17 - line 24 * * page 38, line 21 - page 39, line 25 *;
 [AD]DE202016104645U  (PROTZEK GES FÜR BIOMEDIZINISCHE TECHNIK GMBH [CH]) [AD] 1-14 * the whole document *;
 [A]  - Patricia Zane ET AL, "Dried blood spots: the future", Microsampling in Pharmaceutical Bioanalysis, Unitec House, 2 Albert Place, London N3 1QB, UK, Future Science Ltd, (201312), pages 48 - 66, doi:10.4155/ebo.13.442, ISBN 978-1-909453-58-6, XP055382813 [A] 1-14 * figure 4.2. *

DOI:   http://dx.doi.org/10.4155/ebo.13.442
 [A]  - EDELBROEK PETER M ET AL, "Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls", THERAPEUTIC DRUG MONITOR, LIPPINCOTT WILLIAMS AND WILKINS, NEW YORK, NY, US, (200906), vol. 31, no. 3, ISSN 0163-4356, pages 327 - 336, XP009126006 [A] 1-14 * page 329, column rh, paragraph 5 - paragraph 6 *
ExaminationUS2008299010
 EP2420831
by applicantDE202014002369U
 DE202016104645U
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.